Aspirin Use Doesn ' t Cut Cancer Incidence in Older T2DM Patients
MONDAY, June 25, 2018 -- For Japanese patients with type 2 diabetes, low-dose aspirin is not associated with reduced cancer incidence, except in those younger than 65 years, according to a study published online June 16 in Diabetes Care.
Sadanori...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Aspirin | Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Endocrinology | Japan Health | Pharmaceuticals | Study